Thomas J. Shaw Purchases 15,363 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 15,363 shares of the stock in a transaction on Wednesday, April 17th. The stock was acquired at an average price of $1.03 per share, with a total value of $15,823.89. Following the completion of the acquisition, the chief executive officer now directly owns 14,352,831 shares of the company’s stock, valued at $14,783,415.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Retractable Technologies Price Performance

RVP stock opened at $1.06 on Friday. The company has a quick ratio of 6.41, a current ratio of 8.28 and a debt-to-equity ratio of 0.01. The business has a 50-day moving average of $1.20 and a 200-day moving average of $1.16. Retractable Technologies, Inc. has a fifty-two week low of $0.95 and a fifty-two week high of $1.87.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Retractable Technologies in a report on Wednesday. They issued a “hold” rating for the company.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. WealthTrust Axiom LLC boosted its position in shares of Retractable Technologies by 27.8% during the third quarter. WealthTrust Axiom LLC now owns 126,533 shares of the company’s stock worth $151,000 after buying an additional 27,500 shares during the period. LPL Financial LLC boosted its position in shares of Retractable Technologies by 26.3% during the second quarter. LPL Financial LLC now owns 28,350 shares of the company’s stock worth $109,000 after buying an additional 5,900 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its position in shares of Retractable Technologies by 314.2% during the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 58,400 shares of the company’s stock worth $96,000 after buying an additional 44,300 shares during the period. NewEdge Advisors LLC acquired a new position in shares of Retractable Technologies during the first quarter worth about $77,000. Finally, Royal Bank of Canada boosted its position in shares of Retractable Technologies by 29.7% during the first quarter. Royal Bank of Canada now owns 13,265 shares of the company’s stock worth $63,000 after buying an additional 3,037 shares during the period. 7.58% of the stock is owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.